Striant is a drug owned by Auxilium Pharmaceuticals Llc. It is protected by 1 US drug patent filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Aug 23, 2019. Details of Striant's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US6248358 | Bioadhesive progressive hydration tablets and methods of making and using the same |
Aug, 2019
(5 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Striant is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Striant's family patents as well as insights into ongoing legal events on those patents.
Striant's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Striant's generic launch date based on the expiry of its last outstanding patent is estimated to be Aug 23, 2019 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Striant Generic API suppliers:
Testosterone is the generic name for the brand Striant. 15 different companies have already filed for the generic of Striant, with Actavis Labs Ut Inc having the maximum number of approved applications. Check out the entire list of companies who have already received approval for Striant's generic
Alternative Brands for Striant
Striant which is used for topical or localized delivery of an active ingredient through a progressive hydration bioadhesive system., has several other brand drugs using the same active ingredient (Testosterone). Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.
| Drug Owner | Drug Name | |||
|---|---|---|---|---|
| Acerus |
| |||
| Alza |
| |||
| Antares Pharma Inc |
| |||
| Azurity |
| |||
| Besins Hlthcare |
| |||
| Eli Lilly And Co |
| |||
| Endo Operations |
| |||
| Marius Pharms Llc |
| |||
| Tolmar |
| |||
| Upsher Smith Labs |
| |||
| Verity |
|
Apart from brand drugs containing the same ingredient, some generics have also been filed for Testosterone, Striant's active ingredient. Check the complete list of approved generic manufacturers for Striant
About Striant
Striant is a drug owned by Auxilium Pharmaceuticals Llc. It is used for topical or localized delivery of an active ingredient through a progressive hydration bioadhesive system. Striant uses Testosterone as an active ingredient. Striant was launched by Auxilium Pharms Llc in 2003.
Approval Date:
Striant was approved by FDA for market use on 19 June, 2003.
Active Ingredient:
Striant uses Testosterone as the active ingredient. Check out other Drugs and Companies using Testosterone ingredient
Treatment:
Striant is used for topical or localized delivery of an active ingredient through a progressive hydration bioadhesive system.
Dosage:
Striant is available in tablet, extended release form for buccal use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| 30MG | TABLET, EXTENDED RELEASE | Discontinued | BUCCAL |